A. Dalhoff
Impact in
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
- Pharmacology top 0.5%
- Antibiotics Pharmacokinetics and Efficacy
Papers in
- Pharmacology 78
- Antibiotics Pharmacokinetics and Efficacy 75
-
- Antibiotic Resistance in Bacteria 47
- Co-authors
- Itamar Shalit (1 shared paper)Dagmar Kubitza (1 shared paper)Franz‐Josef Schmitz (1 shared paper)Sabine Schubert (10 shared papers)W. Weidner (2 shared papers)U. Ullmann (5 shared papers)Tom Bergan (1 shared paper)R. Rohwedder (1 shared paper)
- Journals
- Infection (24 papers)Antimicrobial Agents and Chemotherapy (14 papers)Chemotherapy (9 papers)European Journal of Clinical Microbiology & Infectious Diseases (8 papers)Journal of Antimicrobial Chemotherapy (7 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
A. Dalhoff
101 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 120
- Molecular Medicine 826
- Pharmacology 1.3k
- Applied Microbiology and Biotechnology 105
- Clinical Biochemistry 196
- Epidemiology 842
Countries citing papers authored by A. Dalhoff
This map shows the geographic impact of A. Dalhoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Dalhoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Dalhoff more than expected).
Fields of papers citing papers by A. Dalhoff
This network shows the impact of papers produced by A. Dalhoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Dalhoff. The network helps show where A. Dalhoff may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Dalhoff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 108 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 248 | |
| 2 | 2003 | 247 | |
| 3 | 1999 | 161 | |
| 4 | 2005 | 149 | |
| 5 | 2003 | 114 | |
| 6 | 1988 | 101 | |
| 7 | 1997 | 83 | |
| 8 | 2002 | 63 | |
| 9 | 2004 | 62 | |
| 10 | 2009 | 61 | |
| 11 | 1999 | 54 | |
| 12 | 1994 | 54 | |
| 13 | 1998 | 50 | |
| 14 | 1997 | 49 | |
| 15 | 1999 | 48 | |
| 16 | 2005 | 48 | |
| 17 | 1986 | 47 | |
| 18 | 1988 | 45 | |
| 19 | 1985 | 45 | |
| 20 | 2010 | 43 |
About A. Dalhoff
A. Dalhoff is a scholar working on Pharmacology, Molecular Medicine, Epidemiology, Molecular Biology and Infectious Diseases, having authored 108 papers that have together received 2.9k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (75 papers), Antibiotic Resistance in Bacteria (47 papers), Pneumonia and Respiratory Infections (21 papers), Urinary Tract Infections Management (9 papers), Antimicrobial Resistance in Staphylococcus (8 papers), Bacterial Identification and Susceptibility Testing (7 papers), Antibiotic Use and Resistance (7 papers) and Epilepsy research and treatment (6 papers). The work is most often cited by research in Molecular Medicine (826 citations), Pharmacology (1.3k citations), Applied Microbiology and Biotechnology (105 citations), Clinical Biochemistry (196 citations) and Epidemiology (842 citations). A. Dalhoff has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Itamar Shalit, Dagmar Kubitza, Franz‐Josef Schmitz, Sabine Schubert, W. Weidner, U. Ullmann, Tom Bergan, R. Rohwedder, Heinz-Georg Wetzstein and Wolfgang Karl. Their work appears in journals such as Infection, Antimicrobial Agents and Chemotherapy, Chemotherapy, European Journal of Clinical Microbiology & Infectious Diseases and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.